HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Direct Seller Representatives' COVID-19 Claims Sent To FTC By Industry Self-Regulation Group

Executive Summary

RBC Life Sciences may face regulatory scrutiny after ignoring BBB National Programs' questions about sales representatives’ COVID-19 claims and for potential income and its unauthorized use of accreditation logos.

You may also be interested in...



Direct Seller’s Hemp Supplement Claim Fails In Contentious Industry Self-Regulation Review

Q Sciences initially disclaimed responsibility for its independent sales representatives’ claims posted on social media and questioned whether BBB National Programs’ Direct Selling Self-Regulatory Council had jurisdiction to review advertising for its nutritional, fitness, weight-loss, energy and hemp products.

FTC Familiar With Direct Seller’s COVID-19 Claims Questioned By US Industry Self-Regulation Group

Direct Selling Self-Regulatory Council say after UWell Life didn’t respond to its requests to substantiate ad claims made online for Primocyn brand topicals, the council submitted to its concerns to the FTC.

International Sales Reps’ COVID-19 Claims Bring Problems Home For US Supplement Direct Seller

"While several of the posts emanated from overseas, a number of the active posts include US area codes and contact email addresses and appear to have originated in North America,” industry self-regulation group says of Gano Excel.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151076

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel